ApplyBlast uses AI to match you with the right jobs, tailor your resume and cover letter, and apply automatically so you can land your dream job faster.

Features

Auto Apply Resume Optimizer Cover Letter Optimizer Interview Prep

Company

Social Media

Need Help?

team@applyblast.com

Senior Director, SEC Reporting & SOX at Eikon Therapeutics - ApplyBlast

Senior Director, SEC Reporting & SOX

Eikon Therapeutics

7 months ago

3.3 on Glassdoor

Millbrae, CA

Onsite

Full Time

Senior

0 applicants

View Job Listing

Apply to 100+ jobs

About this role

The Senior Director, SEC Reporting & SOX at Eikon Therapeutics leads the company’s external reporting, internal controls, and technical accounting. This role sets strategy for SEC reporting, SOX compliance, and financial governance, translating company objectives into scalable execution and serving as a trusted advisor to executive leadership.

Skills

Qualifications

Bachelor's degree with 15+ years of experience or a post-graduate degree in Finance and Accounting12+ years of experience in public accounting and/or related industry experience6+ years with a technical accounting focusExtensive experience leading SEC reporting and SOX compliance in a public or recently public companyStrong understanding of US GAAP, SEC regulations, SOX, and internal control frameworks

About Eikon Therapeutics

eikontx.com

Headquarters

Millbrae, California, United States

Company Size

201-500 employees

Founded

2019

View Profile

Eikon Therapeutics is a biotechnology company that advances breakthrough therapeutics through the purposeful integration of science and engineering. The company has built a proprietary discovery platform that combines high‑resolution structural and single‑particle imaging (including cryo‑EM), automated experimental engineering, and computational/AI methods to map protein conformational landscapes and identify novel small‑molecule modulators. That platform is used to accelerate target identification, structure‑enabled design, and lead optimization across multiple therapeutic areas through internal programs and external partnerships. Headquartered in Cambridge, MA, Eikon emphasizes an engineering‑first approach to tackle challenging protein targets and shorten drug discovery timelines.